首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   976篇
  免费   57篇
  国内免费   36篇
耳鼻咽喉   13篇
儿科学   15篇
妇产科学   9篇
基础医学   209篇
口腔科学   2篇
临床医学   59篇
内科学   207篇
皮肤病学   10篇
神经病学   5篇
特种医学   27篇
外科学   175篇
综合类   85篇
预防医学   5篇
眼科学   4篇
药学   28篇
肿瘤学   216篇
  2024年   2篇
  2023年   9篇
  2022年   7篇
  2021年   24篇
  2020年   21篇
  2019年   26篇
  2018年   22篇
  2017年   22篇
  2016年   32篇
  2015年   28篇
  2014年   56篇
  2013年   53篇
  2012年   45篇
  2011年   53篇
  2010年   51篇
  2009年   35篇
  2008年   44篇
  2007年   46篇
  2006年   41篇
  2005年   41篇
  2004年   44篇
  2003年   31篇
  2002年   31篇
  2001年   29篇
  2000年   19篇
  1999年   20篇
  1998年   23篇
  1997年   14篇
  1996年   19篇
  1995年   22篇
  1994年   12篇
  1993年   13篇
  1992年   10篇
  1991年   20篇
  1990年   12篇
  1989年   15篇
  1988年   9篇
  1987年   10篇
  1986年   12篇
  1985年   1篇
  1984年   8篇
  1983年   6篇
  1982年   9篇
  1981年   5篇
  1980年   6篇
  1979年   5篇
  1978年   3篇
  1977年   2篇
  1976年   1篇
排序方式: 共有1069条查询结果,搜索用时 0 毫秒
21.
22.
Most ureteral tumors are transitional cell neoplasms. Neuroendocrine tumors of the genitourinary tract are extremely rare. To our knowledge, only one ureteral carcinoid tumor has been reported before. We report a second case of ureteral carcinoid tumor found in a 70-year-old female.  相似文献   
23.

Background

Little is known about the long-term prognosis of small bowel carcinoids because currently no staging system exists.

Methods

A search of the Surveillance, Epidemiology and End Results (SEER) database identified 6,380 patients with small bowel carcinoid tumors from 1977 to 2004. Patients were analyzed according to various clinicopathologic factors and a tumor (T1, T2, T3), lymph node (N0, N1), and metastasis (M0, M1) staging system was created according to these parameters.

Results

Among the 6,380 patients, 2,985 women and 3,395 men, with a median age of 66 years (range 14-98), the median tumor size was 1.9 cm (range .1-30 cm). Multivariate analysis demonstrated that age, size of the primary tumor, and depth of invasion were significant factors. Four stages were created according to statistically significant prognostic factors: 13% of patients were classified into stage I, 31% into stage II, 16% into stage III, and 40% into stage IV. Five-year survival rates were 96%, 87%, 74%, and 43% for stages I through IV, respectively.

Conclusions

The newly developed TNM staging system accurately discriminates prognosis for small bowel carcinoid tumors.  相似文献   
24.
为探讨直肠类癌的临床特点、诊断、治疗及预后,回顾分析26例直肠类癌患者的临床资料,并进行随访。结果显示,26例患者中,男性多于女性;平均年龄51岁;肿瘤位于距肛缘8cm以内直肠为21例(80.8%);主要临床表现为肛周坠胀不适(4例)、大便带血(10例)、排便习惯改变(7例)、不完全性肠梗阻(1例),无症状者健康体检时发现(4例);诊断主要依赖于直肠指检、直肠镜检查、电子结肠镜检查及活检结果;26例均行手术治疗且经术后病理证实;术后5年生存率76.9%(20/26)。结果表明,直肠指检对发现直肠类癌有重要作用,影响直肠类癌预后的主要因素为肿瘤大小、肿瘤的浸润及转移情况;早期诊断及早期个体化的手术是治疗本病的关键。  相似文献   
25.

Background and Objectives:

An open, second-look laparotomy often is required to assess ischemic bowel after extensive mesenteric lymphadenectomy to cytoreduce midgut carcinoids. Aggressive resection of tumor at the base of the mesentery may compromise the integrity of the blood supply to the involved segment of intestine. Long segments of bowel that initially appear ischemic are sometimes created. The surgeon is faced with the decision to perform a resection or to close the abdomen temporarily knowing that this patient will require a second-look laparotomy.

Methods:

Segments of bowel showing signs of possible ischemia were preserved based on signs of perfusion. A side-side anastomosis was performed in the standard fashion. A Jackson Pratt drain was placed in an area adjacent to the anastomosis and brought out through the abdominal wall, and the incision was closed. Forty-eight hours later, a laparoscopic second-look operation was performed. A pneumoperitoneum was established using the drain tubing as the CO2 inflation port. The drain was removed, and a 5-mm trocar was inserted into the abdomen via its tract. Segments of previously questionable dusky bowel and the anastomosis were inspected with a laparoscope.

Results:

Our 3 second-look operations were completed in approximately 5 minutes, and the patients recovered without complication or prolonged hospital course. Our fourth patient progressed extremely well postoperatively and was able to avoid the planned second-look laparos-copy.

Conclusions:

This technique provides an easy solution for the intraoperative finding of questionable blood supply in the intestines.  相似文献   
26.
2000~2005年我国类癌文献计量分析   总被引:2,自引:0,他引:2  
罗志宏  娄钦  王芹 《重庆医学》2007,36(3):233-234,236
目的 从文献外部特征介绍我国近6年对类癌研究的概况.方法 运用FULLTEXT='类癌/fld=关键词,题名,外文题名,摘要 AND #年>=2000 AND #年<=2005'检索表达式从CMCC数据库获取所有文献,并对文献各项外部特征进行分项统计.结果共检得728篇,主要作者、发文机构、刊文期刊、刊文地区、发病部位以及基金资助等,依次为马毅(5篇),中国医学科学院、中国协和医科大学(19篇),诊断病理学杂志(24篇),北京市85 篇,阑尾70篇,32篇得到基金资助.结论 对我国近6年类癌研究的概况进行了描述,有助研究者更上一层楼.  相似文献   
27.
目的:探讨卵巢囊性成熟性畸胎瘤并发类癌的临床特点、诊断思路、治疗方法及预后,总结该类疾病的基本特征,提高临床医生对该病的认识。方法:患者因体检发现一侧卵巢肿物入院,行相关肿瘤标记物检查均未见异常,术前诊断为卵巢瘤,2例患者行患侧附件切除术,1例行患侧肿瘤剥除术。结果:3例患者手术顺利,术后病理诊断均为卵巢成熟性囊性畸胎瘤并发类癌,术后恢复良好,随访15个月未见复发及转移。结论:卵巢囊性成熟性畸胎瘤并发类癌术前极易误诊。患侧附件切除术是治疗该种疾病较为常见的手术方式,预后较好。  相似文献   
28.
29.
目的探讨十二指肠类癌的诊断及治疗方法。方法回顾性分析2000年1月~2007年8月收治的4例十二指肠类癌并复习国内近7年10篇文献报道的29例病例资料。结果诊断方法主要为胃镜、超声检查、电子计算机扫描X线体层摄影、磁共振、上消化道造影等,确诊需要病理学诊断,多需要免疫组织化学帮助。本组中行内镜下切除4例,手术局部切除4例,十二指肠肠段切除8例,胰头十二指肠切除11例。结论治疗主要以手术为主,选择局部切除、十二指肠肠段切除及胰头十二指肠切除等术式。对中晚期或广泛转移的患者可采用联合化疗。药物治疗主要是尽可能减少具有生物活性胺类物质的分泌,缓解、控制类癌综合征的发生,减轻肿瘤的生物化学作用。  相似文献   
30.

Purpose

In the placebo-controlled Phase III TELESTAR (Telotristat Etiprate for Somatostatin Analogue Not Adequately Controlled Carcinoid Syndrome) trial, the oral tryptophan hydroxylase inhibitor telotristat ethyl significantly reduced bowel movement (BM) frequency during a 12-week, double-blind treatment period in 135 patients with metastatic neuroendocrine tumors with carcinoid syndrome and ≥4 BMs per day. Patients (mean [SD] age, 63.5 [8.9] years; mean [SD] body mass index, 24.9 [4.9] kg/m2) received placebo, telotristat ethyl 250 mg, or telotristat ethyl 500 mg 3 times per day (TID) in addition to somatostatin analogue therapy. Weight loss is associated with uncontrolled carcinoid syndrome and may be associated with reduced survival.

Methods

Assessment of the occurrence of weight change ≥3% at week 12 was prespecified in the statistical analysis plan.

Findings

In 120 patients with weight data available, weight gain ≥3% was observed in 2 of 39 patients (5.1%) taking placebo TID, 7 of 41 (17.1%) taking telotristat ethyl 250 mg TID, and 13 of 40 (32.5%) taking telotristat ethyl 500 mg TID (P = 0.0017) at week 12. Weight loss ≥3% was observed in 5 of 39 patients (12.8%) taking placebo TID, 4 of 41 (9.8%) taking telotristat ethyl 250 mg TID, and 6 of 40 (15.0%) taking telotristat ethyl 500 mg TID (P = 0.77). Biochemical and metabolic parameters of serum albumin and cholesterol significantly increased (P = 0.02 and P = 0.001, respectively) in patients gaining weight and decreased in patients who lost weight, suggesting an improvement in overall nutritional status.

Implications

Up to 32.5% of patients treated with telotristat ethyl experienced significant, dose-dependent weight gain, associated with reduced diarrhea severity and improved biochemical and metabolic parameters. Improved nutritional status could be an additional aspect of telotristat ethyl efficacy among patients with functioning metastatic neuroendocrine tumors. ClinicalTrials.gov identifier: NCT01677910.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号